INTRODUCTION:
Oral appliance (OA) therapy is ineffective in some individuals with obstructive sleep apnea (OSA). The reasons for this remain unclear, but may relate to disproportionate collapsibility of the velopharyngeal airway or high nasal resistance. This study sought to assess the effect on OSA severity of a new OA that addresses such possibilities by providing an alternative (oral) route of breathing to conventional OA devices (Oventus, O2Vent T).
METHODS:
Participants were recruited from those already using an OA for treatment of OSA. Each underwent 3 separate PSG studies. PSG #1 was undertaken to determine baseline OSA severity (AHI, apnea hypopnea index) without the OA device. The new OA device with oral route OPEN was titrated during PSG #2 to determine optimal device advancement. This degree of advancement was used in PSG #3 to determine the effect on AHI when with oral route OPEN vs CLOSED (half night under each condition, order randomised).
RESULTS:
Preliminary data have been obtained in 3 male participants aged 61.3±5.7 yrs with BMI 27.0±1.0 kg.m-2 (see Table) . OSA severity was decreased in all individuals with the OA device and oral route CLOSED. Further marked decreases in OSA severity were seen in two of the three individuals when the oral route was OPEN. 
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Instrumentation/Analysis
• For all PSG studies participants wore a full face mask which was partitioned into nasal and oral sections and each connected to pneumotachographs to measure nasal and oral flow
• For PSG #1 & #3, a catheter was inserted via the nares to measure pressure at the retro-palatal, retro-glossal, hypo-pharyngeal and oesophageal regions
• Nasal resistance at a flow of 0.1 l.sec -1 was determined (from the relationship between UA pressures & nasal flow) during wakeful supine nasal breathing in the evening prior to PSG #1 & #3
• PSGs were scored according to AASM 2012 criteria with oral flow used to differentiate apnoeas and hypopnoeas
• Responders to the O 2 Vent T were those with AHI (CLOSED) and/or AHI (OPEN) <50% AHI (BASELINE)
Conclusion
• Provision of an oral route of breathing in an OA device further reduces OSA severity in some individuals using OA therapy, suggesting bypass of nasal/nasopharyngeal obstruction.
• Further data is required to fully elucidate mechanisms and characteristics of individuals who may benefit from an OA with an oral breathing route. However, this preliminary data suggests that the degree of efficacy of this novel OA device appears to be greater in those with higher nasal resistance
Aims
• Examine the efficacy of the O 2 Vent T with oral breathing route CLOSED and OPEN for the treatment of OSA
• Identify responders and non-responders to the O 2 Vent T
• Assess the relationship between nasal resistance and effect of the O 2 Vent T (oral route CLOSED and OPEN) on OSA severity
Results
• Relative to BASELINE OSA, severity was decreased in 8/10 individuals with the O 2 Vent T oral route CLOSED. Relative to CLOSED, with the O 2 Vent T oral route OPEN, OSA severity was further decreased in 6/8 participants (Fig 1) UWA Centre for Sleep Science & West Australian Sleep Disorders Research Institute • Changes in a number of other measures of OSA severity including O 2 desaturation index 4%, supine AHI and arousal indices from BASELINE to CLOSED and/or OPEN were also related to nasal resistance
• Preliminary data have been obtained in 10 participants (8 male • Nasal resistance was not related to OSA severity at BASELINE, CLOSED or OPEN (all r 2 <0.10) but was related to mean snoring intensity (dB) during CLOSED (r 2 =0.50; p<0.05)
• Higher nasal resistance prior to PSG #3 was associated with a greater reduction in AHI from BASELINE during OPEN (r 2 =0.60, p<0.05) but not when the device airway was CLOSED (r 2 =0.28, p=0.14; Fig 
